JKB-122

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
95	自己免疫性肝炎	3

95. 自己免疫性肝炎

臨床試験数 : 52 / 薬物数 : 68 - (DrugBank : 27) / 標的遺伝子数 : 18 - 標的パスウェイ数 : 111

trials per page:

Showing 1 to 3 of 3 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04371718 (ClinicalTrials.gov)	November 2020	29/4/2020	Effect of JKB-122 on Prednisolone and Azathioprine Induced Remission in Autoimmune Hepatitis (AIH)	A Phase II, Randomized, Double-Blind, Placebo Controlled, Trial of JKB-122as an Adjunct Therapy to P ...	Autoimmune Hepatitis	Drug: JKB-122;Other: Placebo	TaiwanJ Pharmaceuticals Co., Ltd	NULL	Not yet recruiting	18 Years	65 Years	All	120	Phase 2	NULL
2	NCT04313205 (ClinicalTrials.gov)	August 2020	16/3/2020	A Pharmacokinetic Study of JKB-122 Tablets Compared to Capsule	A Randomized, Open-label, Multiple-dose, Two-period, Crossover, Study to Investigate the Pharmacokin ...	Autoimmune Hepatitis	Drug: JKB-122 in capsule or tablet form	TaiwanJ Pharmaceuticals Co., Ltd	NULL	Not yet recruiting	20 Years	45 Years	Male	8	Phase 1	NULL
3	NCT02556372 (ClinicalTrials.gov)	April 30, 2016	20/9/2015	Liver Test Study of Using JKB-122in Autoimmune Hepatitis (AIH) Patients Who Are Refractory or Intole ...	A Phase 2, Pilot Study of JKB-122to Assess Liver Tests (ALT) in Autoimmune Hepatitis (AIH) Patients ...	Autoimmune Hepatitis	Drug: JKB-122	TaiwanJ Pharmaceuticals Co., Ltd	NULL	Completed	18 Years	N/A	All	20	Phase 2	United States

First Previous1Next Last